FDA Panel Votes in Favor of Effectiveness of Forest Labs’ Daxas

FDA Panel Votes in Favor of Effectiveness of Forest Labs’ Daxas – Dow Jones reports that US FDA Panel has voted 9-6 in favor of Forest Labs (FRX), Nycomed drug Daxas which has shown effectiveness for COPD maintenance.

Create Content With AI

Risk Our Money Not Yours | Get 50% Off Any Account

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


*

This site uses Akismet to reduce spam. Learn how your comment data is processed.